Molecular footprints of human lung cancer progression

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Gene expression profiling predicts clinical outcome of breast cancer

van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · see citing works

A multigenic program mediating breast cancer metastasis to bone

Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,562 · see citing works

A molecular signature of metastasis in primary solid tumors

Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2002) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,448 · see citing works

Metastasis genes: A progression puzzle

Bernards, R., & Weinberg, R. A. (2002) · Nature · doi:10.1038/418823a · Cited by 801 · see citing works

From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

Schmidt‐Kittler, O., Ragg, T., Daskalakis, A., Granzow, M., Ahr, A., Blankenstein, T. J. F., Kaufmann, M., Diebold, J., Arnholdt, H., Müller, P. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1331931100 · Cited by 631 · see citing works

The genetics and genomics of cancer

Balmain, A., Gray, J. W., & Ponder, B. A. J. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573 · see citing works

Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.

Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H., & Alexandrov, K. (2000) · PubMed · Cited by 569 · see citing works

Focus on lung cancer

Minna, J. D., Roth, J. A., & Gazdar, A. F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00027-2 · Cited by 553 · see citing works

Tumor progression and metastasis

Yokota, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.497 · Cited by 426 · see citing works

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

Zabarovsky, E. R., Lerman, M. I., & Minna, J. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205835 · Cited by 383 · see citing works

Patterns of p53 G->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke

Hainaut, P. (2001) · Carcinogenesis · doi:10.1093/carcin/22.3.367 · Cited by 375 · see citing works

Alterations of myc , myb , and ras Ha Proto-Oncogenes In Cancers Are Frequent and Show Clinical Correlation

Yokota, J., Tsunetsugu‐Yokota, Y., Battifora, H. A., Fevre, C. L., & Cline, M. J. (1986) · Science · doi:10.1126/science.3941898 · Cited by 371 · see citing works

Clinical significance of ras oncogene activation in human lung cancer

Therapy, E. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 361 · see citing works

Altered methylation patterns in cancer cell genomes: Cause or consequence?

Baylin, S. B., & Bestor, T. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00061-2 · Cited by 280 · see citing works

hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.

Sugimura, H., Kohno, T., Wakai, K., Nagura, K., Genka, K., Igarashi, H., Morris, B., Baba, S., Ohno, Y., Gao, C., et al. (1999) · PubMed · Cited by 235 · see citing works

The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung

Divine, K. K., Gilliland, F. D., Crowell, R. E., Stidley, C. A., Bocklage, T. J., Cook, D. L., & Belinsky, S. A. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00059-8 · Cited by 220 · see citing works

The p53 codon 72 polymorphism and lung cancer risk.

Fan, R., Wu, M., MILLER, D. P., Wain, J. C., Kelsey, K. T., Wiencke, J. K., & Christiani, D. C. (2000) · PubMed · Cited by 183 · see citing works

Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.

Shapiro, G. I., Park, J. E., Edwards, C. D., Mao, L., Merlo, A. U., Sidransky, D., Ewen, M. E., & Rollins, B. J. (1995) · PubMed · Cited by 181 · see citing works

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer

Kaye, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205834 · Cited by 153 · see citing works

The p53 network in lung carcinogenesis

Robles, A. I., Linke, S. P., & Harris, C. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205563 · Cited by 136 · see citing works

Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.

Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H., & Yokota, J. (1994) · PubMed · Cited by 133 · see citing works

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.

Sunaga, N., Kohno, T., Yanagitani, N., Sugimura, H., Kunitoh, H., Tamura, T., 武井, 義., Tsuchiya, S., Saito, R., & Yokota, J. (2002) · PubMed · Cited by 126 · see citing works

Manganese Superoxide Dismutase Alanine-to-Valine Polymorphism at Codon 16 and Lung Cancer Risk

Wang, L. I., Miller, D. P., Sai, Y., Liu, G., Su, L., Wain, J. C., Lynch, T. J., & Christiani, D. C. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.23.1818 · Cited by 125 · see citing works

How many tumor suppressor genes are involved in human lung carcinogenesis?

Kohno, T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1403 · Cited by 105 · see citing works

Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.

Johnson, B. E., Battey, J. F., Linnoila, I. R., Becker, K. L., Makuch, R., Snider, R. H., Carney, D. N., & Minna, J. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112604 · Cited by 104 · see citing works

MYO18B , a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer

Nishioka, M., Kohno, T., Tani, M., Yanaihara, N., Tomizawa, Y., Otsuka, A., Sasaki, S., Kobayashi, K., Niki, T., Maeshima, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192445899 · Cited by 103 · see citing works

Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors

Gray, J. W. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00167-3 · Cited by 102 · see citing works

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma

Tomizawa, Y., Kohno, T., Fujita, T., Kiyama, M., Saito, R., Noguchi, M., Matsuno, Y., Hirohashi, S., Yamaguchi, N., Nakajima, T., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202384 · Cited by 89 · see citing works

Chromosome Breaks and Genomic Instability

Jasin, M. (2000) · Cancer Investigation · doi:10.3109/07357900009023065 · Cited by 87 · see citing works

Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes

Yokota, J., Wada, M., Yoshida, T., Noguchi, M., Terasaki, T., Shimosato, Y., Sugimura, T., & Terada, M. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90332-2 · Cited by 82 · see citing works

Comparative allelotype of early and advanced stage non-small cell lung carcinomas

Shiseki, M., Kohno, T., Adachi, J.-I., Okazaki, T., Otsuka, T., Mizoguchi, H., Noguchi, M., Hirohashi, S., & Yokota, J. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199610)17:2 · Cited by 79 · see citing works

Molecular processes of chromosome 9p21 deletions in human cancers

Sasaki, S., Kitagawa, Y., Sekido, Y., Minna, J. D., Kuwano, H., Yokota, J., & Kohno, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206589 · Cited by 69 · see citing works

Prevalent Involvement of Illegitimate V(D)J Recombination in Chromosome 9p21 Deletions in Lymphoid Leukemia

Kitagawa, Y., Inoue, K., Sasaki, S., Hayashi, Y., Matsuo, Y., Lieber, M. R., Mizoguchi, H., Yokota, J., & Kohno, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208353200 · Cited by 56 · see citing works

Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations.

Ookawa, K., Shiseki, M., Takahashi, R., Yoshida, Y., Terada, M., & Yokota, J. (1993) · PubMed · Cited by 44 · see citing works

Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.

Adachi, J.-I., Ookawa, K., Shiseki, M., Okazaki, T., Tsuchida, S., Morishita, K., & Yokota, J. (1996) · PubMed · Cited by 25 · see citing works

Genetic alterations responsible for metastatic phenotypes of lung cancer cells

Yokota, J., Nishioka, M., Tani, M., & Kohno, T. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022978932215 · Cited by 24 · see citing works

Activation of RB tumor suppressor protein and growth suppression of small cell lung carcinoma cells by reintroduction of p16INK4A gene.

Sumitomo, K., Shimizu, E., Shinohara, A., Yokota, J., & Sone, S. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.6.1075 · Cited by 23 · see citing works

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1

Yanagitani, N. (2002) · Carcinogenesis · doi:10.1093/carcin/23.7.1177 · Cited by 21 · see citing works

Metastasis: the role of chance in malignancy

Edwards, P. A. (2002) · Nature · doi:10.1038/419559b · Cited by 16 · see citing works

Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression

Adachi, J.-I., Ookawa, K., Kohno, T., Tomizawa, Y., Tsuchida, S., & Yokota, J. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400325 · Cited by 16 · see citing works

Metastasis: objections to the same-gene model

Sherley, J. L. (2002) · Nature · doi:10.1038/419560a · Cited by 10 · see citing works

Identification of D19S246 as a novel lung adenocarcinoma susceptibility locus by genome survey with 10-cM resolution microsatellite markers.

Yanagitani, N., Kohno, T., Kim, J.-G., Kunitoh, H., Tamura, T., 武井, 義., Tsuchiya, S., Saito, R., & Yokota, J. (2003) · PubMed · Cited by 8 · see citing works

Growth suppression of non-small cell lung carcinoma cells by the introduction of the p16(INK4A) gene

Adachi, J., Kohno, T., Baeg, G., Akiyama, T., & Yokota, J. (1997) · International Journal of Oncology · doi:10.3892/ijo.10.1.33 · Cited by 7 · see citing works

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · see citing works

Ras in Cancer and Developmental Diseases

Fernández‐Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 959 · see citing works

Mechanisms of PTEN loss in cancer: It’s all about diversity

Garcia, V. A., Tawil, Y., Wise, H. M., & Leslie, N. R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.02.001 · Cited by 407 · see citing works

KRAS mutation in pancreatic cancer

Luo, J. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.02.003 · Cited by 360 · see citing works

<i>TP53</i> and <i>KRAS</i> Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers

Le Calvez, F., Mukeria, A., Hunt, J. D., Kelm, O., Hung, R. J., Tanière, P., Brennan, P., Boffetta, P., Zaridze, D. G., & Hainaut, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0551 · Cited by 273 · see citing works

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

Kalikaki, A., Koutsopoulos, A. V., Trypaki, M., Souglakos, J., Stathopoulos, E. N., Georgoulias, V., Mavroudis, D., & Voutsina, A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604629 · Cited by 202 · see citing works

Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma

Kim, K.-T., Lee, H. W., Lee, H.-O., Song, H. J., Jeong, D. E., Shin, S., Kim, H., Shin, Y., Nam, D.-H., Jeong, B. C., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0945-9 · Cited by 198 · see citing works

Drugging KRAS: Current perspectives and state-of-art review

Parikh, K., Banna, G., Liu, S. V., Friedlaender, A., Desai, A., Subbiah, V., & Addeo, A. (2022) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-022-01375-4 · Cited by 164 · see citing works

TAZ is a novel oncogene in non-small cell lung cancer

Zhou, Z., Hao, Y., Liu, N., Raptis, L. H., Tsao, M., & Yang, X. (2011) · Oncogene · doi:10.1038/onc.2010.606 · Cited by 164 · see citing works

Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis

Murakami, Y. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00089.x · Cited by 162 · see citing works

Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome

Dickens, N. J., Walker, B. A., Leone, P., Johnson, D. C., Brito, J. L. R., Zeisig, A., Jenner, M. W., Boyd, K. D., Gonzalez, D., Gregory, W. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2831 · Cited by 125 · see citing works

YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting

Sardo, F. L., Strano, S., & Blandino, G. (2018) · Cancers · doi:10.3390/cancers10050137 · Cited by 120 · see citing works

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib

Yin, Y., Shu, Y., Zhu, J., Li, F., & Li, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-23834-1 · Cited by 120 · see citing works

The genetics and biology of KRAS in lung cancer

Westcott, P. M. K., & To, M. D. (2013) · Chinese Journal of Cancer · doi:10.5732/cjc.012.10098 · Cited by 116 · see citing works

Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma

Hammoud, Z. T., Tan, B., Badve, S., & Bigsby, R. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0002 · Cited by 108 · see citing works

MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways

Oneyama, C., Ikeda, J., Okuzaki, D., Suzuki, K., Kanou, T., Shintani, Y., Morii, E., Okumura, M., Aozasa, K., & Okada, M. (2011) · Oncogene · doi:10.1038/onc.2011.63 · Cited by 101 · see citing works

Involvement of LKB1 in epithelial–mesenchymal transition (EMT) of human lung cancer cells

Roy, B. C., Kohno, T., Iwakawa, R., Moriguchi, T., Kiyono, T., Morishita, K., Sánchez‐Céspedes, M., Akiyama, T., & Yokota, J. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.02.004 · Cited by 93 · see citing works

Coexpression of Actin-Related Protein 2 and Wiskott-Aldrich Syndrome Family Verproline-Homologous Protein 2 in Adenocarcinoma of the Lung

Semba, S., Iwaya, K., Matsubayashi, J., Serizawa, H., Kataba, H., Hirano, T., Kato, H., Matsuoka, T., & Mukai, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2566 · Cited by 89 · see citing works

Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer

Sato, M., Takahashi, K., Nagayama, K., Arai, Y., Ito, N., Okada, M., Minna, J. D., Yokota, J., & Kohno, T. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20253 · Cited by 86 · see citing works

A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene

Kohno, T., Otsuka, A., Girard, L., Sato, M., Iwakawa, R., Ogiwara, H., Sánchez‐Céspedes, M., Minna, J. D., & Yokota, J. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20746 · Cited by 84 · see citing works

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction

Fortunato, O., Boeri, M., Moro, M., Verri, C., Mensah, M., Conte, D., Caleca, L., Roz, L., Pastorino, U., & Sozzi, G. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.507 · Cited by 83 · see citing works

Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: Etiopathogenic similarities, differences and paradoxes

Porta, M. S., Crous‐Bou, M., Wark, P. A., Vineis, P., Real, F. X., Malats, N., & Kampman, E. (2009) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2009.07.003 · Cited by 83 · see citing works

Modulation of Cell Cycle Components by Epigenetic and Genetic Events

Macaluso, M., Montanari, M., Cinti, C., & Giordano, A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.009 · Cited by 83 · see citing works

The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells

Chen, M. C., Chen, C. H., Wang, J.-C., Tsai, A.-C., Liou, J.-P., Pan, S.-L., & Teng, C.-M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.330 · Cited by 80 · see citing works

Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles

Sathipati, S. Y., & Ho, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07739-y · Cited by 74 · see citing works

miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells

Xie, X., Liu, H., Wang, M., Ding, F., Xiao, H., Hu, F., Hu, R., & Mei, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3154-3 · Cited by 73 · see citing works

Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung Tumors

Mechanic, L. E., Bowman, E. D., Welsh, J. A., Ma, K., Hagiwara, N., Enewold, L., Shields, P. G., Burdette, L. A., Chanock, S. J., & Harris, C. C. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0790 · Cited by 70 · see citing works

Three-dimensional culture model to distinguish normal from malignant human bronchial epithelial cells

Fessart, D., Bégueret, H., & Delom, F. (2013) · European Respiratory Journal · doi:10.1183/09031936.00118812 · Cited by 68 · see citing works

Highly concordant coexpression of aromatase and estrogen receptor β in non–small cell lung cancer

Abe, K., Miki, Y., Ono, K., Mori, M., Kakinuma, H., Kou, Y., Kudo, N., Koguchi, M., Niikawa, H., Suzuki, S., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.07.010 · Cited by 66 · see citing works

Prognostic Implications of Molecular and Immunohistochemical Profiles of the Rb and p53 Cell Cycle Regulatory Pathways in Primary Non–Small Cell Lung Carcinoma

Burke, L. M., Flieder, D. B., Guinee, D. G., Brambilla, E., Freedman, A. N., Bennett, W. P., Jones, R. T., Borkowski, A., Caporaso, N. A., Fleming, M. V., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.232.11.1 · Cited by 64 · see citing works

Homozygous deletion scanning of the lung cancer genome at a 100‐kb resolution

Nagayama, K., Kohno, T., Sato, M., Arai, Y., Minna, J. D., & Yokota, J. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20485 · Cited by 61 · see citing works

Polymorphisms in XPD and TP53 and mutation in human lung cancer

Mechanic, L. E. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh344 · Cited by 61 · see citing works

Extracellular Vesicles (EVs) from Lung Adenocarcinoma Cells Promote Human Umbilical Vein Endothelial Cell (HUVEC) Angiogenesis through Yes Kinase-associated Protein (YAP) Transport

Wang, Y., Dong, L., Zhong, H., Yang, L., Li, Q., Su, C., Gu, W., & Qian, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31605 · Cited by 59 · see citing works

KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways

Mondal, K., Posa, M. K., Shenoy, R. P., & Roychoudhury, S. (2024) · Cells · doi:10.3390/cells13141221 · Cited by 56 · see citing works

Comparison of p53 and Epidermal Growth Factor Receptor Gene Status Between Primary Tumors and Lymph Node Metastases in Non-Small Cell Lung Cancers

Chang, Y., Wu, C., Shih, J., & Lee, Y.-C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1295-6 · Cited by 56 · see citing works

Co-Activation of Epidermal Growth Factor Receptor and c-MET Defines a Distinct Subset of Lung Adenocarcinomas

Matsubara, D., Ishikawa, S., Oguni, S., Aburatani, H., Fukayama, M., & Niki, T. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100217 · Cited by 52 · see citing works

Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer

Takahashi, K., Kohno, T., Ajima, R., Sasaki, H., Minna, J. D., Fujiwara, T., Tanaka, N., & Yokota, J. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.2.321 · Cited by 50 · see citing works

Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma

Yoneda, M., Suzuki, T., Nakamura, T., Ajima, R., Yoshida, Y., Kakuta, S., Sudo, K., Iwakura, Y., Shibutani, M., Mitsumori, K., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01030.x · Cited by 47 · see citing works

Different estrogen receptor β expression in distinct histologic subtypes of lung adenocarcinoma

Alì, G., Donati, V. L., Loggini, B., Servadio, A., Dell'Omodarme, M., Prati, M. C., Camacci, T., Lucchi, M., Melfi, F. M. A., Mussi, A., et al. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.02.011 · Cited by 47 · see citing works

Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma

Matsumoto, S., Iwakawa, R., Kohno, T., Suzuki, K., Matsuno, Y., Yamamoto, S., Noguchi, M., Shimizu, E., & Yokota, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21670 · Cited by 46 · see citing works

Elevated Expression of UBE2T in Lung Cancer Tumors and Cell Lines

Hao, J., Xu, A., Xie, X., Hao, J., Tian, T., Gao, S., Xiao, X., & He, D. (2008) · Tumor Biology · doi:10.1159/000148187 · Cited by 43 · see citing works

Lung cancer screening: from imaging to biomarker

Xiang, D., Zhang, B., Doll, D. C., Shen, K., Kloecker, G. H., & Freter, C. E. (2013) · Biomarker Research · doi:10.1186/2050-7771-1-4 · Cited by 43 · see citing works

How to develop a successful cancer drug – molecules to medicines or targets to treatments?

Newell, D. R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.024 · Cited by 42 · see citing works

From cancer genomes to cancer models: bridging the gaps

Baudot, A., Real, F. X., Izarzugaza, J. M. G., & Valencia, A. (2009) · EMBO Reports · doi:10.1038/embor.2009.46 · Cited by 40 · see citing works

Apoptosis Induced by Depsipeptide FK228 Coincides with Inhibition of Survival Signaling in Lung Cancer Cells

Yu, X.-D., Wang, S.-Y., Chen, G. A., Hou, C.-M., Zhao, M., Hong, J. A., Nguyen, D. M., & Schrump, D. S. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e318046eedc · Cited by 40 · see citing works

Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer

Ogiwara, H., Kohno, T., Nakanishi, H., Nagayama, K., Sato, M., & Yokota, J. (2008) · Oncogene · doi:10.1038/onc.2008.113 · Cited by 40 · see citing works

mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis

Borzi, C., Calzolari, L., Centonze, G., Milione, M., Sozzi, G., & Fortunato, O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010222 · Cited by 38 · see citing works

Molecular analysis of the Ink4a/Rb1–Arf/Tp53 pathways in radon-induced rat lung tumors

Bastide, K., Guilly, M., Bernaudin, J., Joubert, C., Lectard, B., Levalois, C., Malfoy, B., & Chevillard, S. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.06.007 · Cited by 38 · see citing works

Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells

Komiya, K., Sueoka‐Aragane, N., Sato, A., Hisatomi, T., Sakuragi, T., Mitsuoka, M., Sato, T., Hayashi, S., Izumi, H., Tsuneoka, M., et al. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0679-0 · Cited by 37 · see citing works

Clonal and Parallel Evolution of Primary Lung Cancers and Their Metastases Revealed by Molecular Dissection of Cancer Cells

Takahashi, K., Kohno, T., Matsumoto, S., Nakanishi, Y., Arai, Y., Yamamoto, S., Fujiwara, T., Tanaka, N., & Yokota, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0659 · Cited by 37 · see citing works

Quantitative Detection of p53 Mutations in Plasma DNA from Tobacco Smokers

Hagiwara, N., Mechanic, L. E., Trivers, G. E., Cawley, H., Taga, M., Bowman, E. D., Kumamoto, K., He, P., Bernard, M., Doja, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0991 · Cited by 37 · see citing works

Hypoxia‐inducible factor‐1α polymorphisms are associated with genetic aberrations in lung cancer

Putra, A. C., Tanimoto, K., Arifin, M., & Hiyama, K. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01972.x · Cited by 36 · see citing works

Hypoxia increases the motility of lung adenocarcinoma cell line A549 via activation of the epidermal growth factor receptor pathway

Wang, T., Niki, T., Goto, A., Ota, S., Morikawa, T., Nakamura, Y., Ohara, E., Ishikawa, S., Aburatani, H., Nakajima, J., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00428.x · Cited by 35 · see citing works

The status of KRAS mutations in patients with non-small cell lung cancers from mainland China

Lü (2009) · Oncology Reports · doi:10.3892/or_00000529 · Cited by 34 · see citing works

Whole Genome Comparison of Allelic Imbalance between Noninvasive and Invasive Small-Sized Lung Adenocarcinomas

Nakanishi, H., Matsumoto, S., Iwakawa, R., Kohno, T., Suzuki, K., Tsuta, K., Matsuno, Y., Noguchi, M., Shimizu, E., & Yokota, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3218 · Cited by 34 · see citing works

Application of infrared spectroscopy for the identification of squamous cell carcinoma (lung cancer). Preliminary study

Kaznowska, E. B., Łach, K., Depciuch, J., Chaber, R., Koziorowska, A. M., Slobodian, S., Kiper, K., Chlebus, A., & Cebulski, J. (2018) · Infrared Physics & Technology · doi:10.1016/j.infrared.2018.01.021 · Cited by 31 · see citing works

Lung Cancer Susceptibility in Fhit-Deficient Mice Is Increased by Vhl Haploinsufficiency

Zanesi, N. A. O., Mancini, R., Sevignani, C., Vecchione, A. M., Kaou, M., Valtieri, M., Calin, G. A., Pekarsky, Y., Gnarra, J. R., Croce, C. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1128 · Cited by 31 · see citing works

miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer

Kang, M., Li, Y., Zhao, Y., He, S., & Shi, J. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1730-2 · Cited by 30 · see citing works

Bovine Genome-wide Association Study for Genetic Elements to Resist the Infection of Foot-and-mouth Disease in the Field

Lee, B., Lee, K., Lee, T., Park, J.-H., Kim, S.-M., Lee, H.-S., Chung, D.-S., Shim, H.-S., Lee, H.-K., & Kim, H. (2014) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.14.0383 · Cited by 29 · see citing works

Expression of a splicing variant of the CADM1 specific to small cell lung cancer

Kikuchi, S., Iwai, M., Sakurai‐Yageta, M., Tsuboi, Y., Ito, T., Maruyama, T., Tsuda, H., Kanai, Y., Onizuka, M., Sato, Y., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02277.x · Cited by 27 · see citing works

Prognostic implications of cell cycle‐related proteins in primary resectable pathologic N2 nonsmall cell lung cancer

Mohamed, S. A. A., Yasufuku, K., Hiroshima, K., Nakajima, T., Yoshida, S., Suzuki, M., Sekine, Y., Shibuya, K., Iizasa, T., Farouk, A., et al. (2007) · Cancer · doi:10.1002/cncr.22651 · Cited by 27 · see citing works

XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: A meta‐analysis

Sun, H., Qiao, Y., Zhang, X., Xu, L., Jia, X., Sun, D., Shen, C., Liu, A., Zhao, Y., Jin, Y., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01608.x · Cited by 24 · see citing works

Determination of sequential mutation accumulation in pancreas and bile duct brushing cytology

Lapkus, O., Gologan, O., Liu, Y., Swalsky, P. A., Wilson, M. M., Finkelstein, S. D., & Silverman, J. F. (2006) · Modern Pathology · doi:10.1038/modpathol.3800545 · Cited by 24 · see citing works

MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway

Zhang, Z., Zhu, J., Huang, Y., Li, W., & Cheng, H. (2018) · Diagnostic Pathology · doi:10.1186/s13000-018-0763-3 · Cited by 23 · see citing works

Subepithelial myofibroblast in lung adenocarcinoma: a histological indicator of excellent prognosis

Matsubara, D., Morikawa, T., Goto, A., Nakajima, J., Fukayama, M., & Niki, T. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.27 · Cited by 23 · see citing works

An in silico analytical study of lung cancer and smokers datasets from gene expression omnibus (GEO) for prediction of differentially expressed genes

Dept. of Bioinformatics, J. M. I., Hasan, A. N., Ahmad, M. W., Madar, I. H., Beslin, L. G., & Hasan, T. N. (2015) · Bioinformation · doi:10.6026/97320630011229 · Cited by 22 · see citing works

Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case–control study and meta-analysis

Deng, Z.-C., Cao, C., Yu, Y., Ma, H., & Ye, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-1241-x · Cited by 21 · see citing works

Molecular changes in smoking-related lung cancer

Begum, S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.84 · Cited by 21 · see citing works

The influence ofTP53mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations

Lee, S. Y., Jeon, H., Hwangbo, Y., Jeong, J. Y., Park, J. Y., Lee, E. J., Jin, G., Shin, K. M., Yoo, S. S., Lee, J., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22077 · Cited by 20 · see citing works

Cancer-associated loss of TARSH gene expression in human primary lung cancer

Terauchi, K., Shimada, J., Uekawa, N., Yaoi, T., Maruyama, M., & Fushiki, S. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0032-1 · Cited by 19 · see citing works

Genomics of lung cancer may change diagnosis, prognosis and therapy

Kopper, L., & Tı́már, J. (2005) · Pathology & Oncology Research · doi:10.1007/bf03032399 · Cited by 19 · see citing works

Rad9 modulates the P21 WAF1 pathway by direct association with p53

Ishikawa, K., Ishii, H., Murakumo, Y., Mimori, K., Kobayashi, M., Yamamoto, K.-I., Mori, M., Nishino, H., Furukawa, Y., & Ichimura, K. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-37 · Cited by 18 · see citing works

Tumor-specific exon 1 mutations could be the ‘hit event’ predisposing Rb2/p130 gene to epigenetic silencing in lung cancer

Cinti, C., Macaluso, M., & Giordano, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208880 · Cited by 18 · see citing works

Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma

Shinmura, K., Hong, T., Nagura, K., Goto, M., Matsuura, S., Mochizuki, T., Suzuki, K. Z., Tanahashi, M., Niwa, H., Ogawa, H., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.04.006 · Cited by 17 · see citing works

Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer

Cho, S., Kim, M. J., Choi, Y. Y., Yoo, S. S., Lee, W. K., Lee, E. J., Jang, E. J., Bae, E. Y., Jin, G., Jeon, H.-S., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.10.023 · Cited by 17 · see citing works

Specifically targeted gene therapy for small-cell lung cancer

Christensen, C. L., Zandi, R., Gjetting, T., Cramer, F., & Poulsen, H. S. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.10 · Cited by 17 · see citing works

Rap2b promotes proliferation, migration, and invasion of lung cancer cells

Peng, Y., Zhang, Z.-Q., Chen, Y., & Huang, J. (2015) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2015.1122044 · Cited by 16 · see citing works

Differential expression of an ensemble of the key genes involved in cell-cycle regulation in lung cancer

Krasnov, G. S., Пузанов, Г. А., Kudryavtseva, A. V., Dmitriev, A. A., Beniaminov, A. D., Kondratieva, T. T., & Senchenko, V. N. (2017) · Molecular Biology · doi:10.1134/s0026893317050107 · Cited by 16 · see citing works

KIF4A knockdown inhibits tumor progression and promotes chemo‐sensitivity via induction of P21 in lung cancer cells

Zhang, D., Lu, W., & Samadi, N. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14153 · Cited by 15 · see citing works

Molecular Imaging in Cancer

Bhojani, M. S., Laxman, B., Ross, B. D., & Rehemtulla, A. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch27 · Cited by 15 · see citing works

First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives

He, Q., Liu, X., Jiang, L., Liu, P., Xuan, W., Wang, Y., Meng, R., Feng, H., Lv, S., Miao, Q., et al. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2441499 · Cited by 13 · see citing works

TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients

Nairuz, T., Rahman, M. M., Bushra, M. U., & Kabir, Y. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.7.2091 · Cited by 13 · see citing works

Annexin A13 predicts poor prognosis for lung adenocarcinoma patients and accelerates the proliferation and migration of lung adenocarcinoma cells by modulating epithelial–mesenchymal transition

Xue, G., Zhang, C., Zheng, G., Zhang, L., & Bi, J. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12555 · Cited by 12 · see citing works

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma

Khadse, A., Haakensen, V. D., Silwal‐Pandit, L., Hamfjord, J., Micke, P., Botling, J., Brustugun, O. T., Lingjærde, O. C., Helland, Å., & Kure, E. H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.873532 · Cited by 11 · see citing works

Common Non-Small-Cell Carcinomas and Their Variants

Flieder, D. B., & Hammar, S. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-72114-9_4 · Cited by 11 · see citing works

Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- 1 haploinsufficiency

Pandey, J. P., Umphress, S. M., Kang, Y., Angdisen, J. J., Naumova, A. V., Mercer, K. L., Jacks, T., & Jakowlew, S. B. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm136 · Cited by 11 · see citing works

Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer

Hiyama (2010) · International Journal of Oncology · doi:10.3892/ijo_00000605 · Cited by 11 · see citing works

Prognostic factors in oral and oropharyngeal cancer based on ultrastructural analysis and DNA methylation of the tumor and surgical margin

Mielcarek-Kuchta, D., Paluszczak, J., Seget, M., Kiwerska, K., Biczysko, W., Szyfter, K., & Szyfter, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-1958-1 · Cited by 10 · see citing works

Patients Lung Derived Tumoroids (PLDTs) to model therapeutic response

Delom, F., Begiristain, I., Grenier, T., Bégueret, H., Soulet, F., Siegfried, G., Khatib, A., Robert, J., & Fessart, D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118808 · Cited by 9 · see citing works

Nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone‐induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2‐adrenergic receptor single‐nucleotide polymorphisms

Masi, T. J., Cekanova, M., Walker, K., Bernert, H., Majidi, M., Becker, J. M., & Schuller, H. M. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20228 · Cited by 9 · see citing works

Mechanisms and markers of carcinogenesis and neoplastic progression

Bödey, B., Bödey, B., & Siegel, S. E. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.10.1317 · Cited by 8 · see citing works

Mining featured micro ribonucleic acids associated with lung cancer based on bioinformatics

Su, L., Li, N., & Huo, X. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12187 · Cited by 7 · see citing works

Prognostic significance of cyclin D1 expression in resected stage I, II non-small cell lung cancer in Arabs

Ayed, A. K. (2005) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2005.120030 · Cited by 7 · see citing works

Nuclear Morphometry of Lung Squamous Cell Carcinomas in Cytologic Study

Nishihira, M., Nakazato, Y., Tsuchida, S., Kuroda, H., Imai, Y., & Chida, M. (2018) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.18-00005 · Cited by 6 · see citing works

Biotransformation enzymes and lung cell response to 2‐hydroxyethyl‐methacrylate

Samuelsen, J. T., Holme, J. A., Låg, M., Schwarze, P. E., Dahl, J. E., & Becher, R. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33287 · Cited by 5 · see citing works

Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines with Wild Type EGFR and Use of KRAS as a Possible Biomarker for Treatment Responsiveness

Miyake, N., Chikumi, H., Yamaguchi, K., Takata, M., Takata, M., Okada, K., Kitaura, T., Nakamoto, M., & Yamasaki, A. (2019) · Yonago acta medica · doi:10.33160/yam.2019.03.012 · Cited by 5 · see citing works

Polymorphism Arg72Pro of p53 Confers Susceptibility to Squamous Cell Carcinoma of Lungs in a North Indian Population

Tilak, A., Kumar, S., Pant, M. C., Mathur, N., & Kumar, A. (2013) · DNA and Cell Biology · doi:10.1089/dna.2012.1792 · Cited by 5 · see citing works

Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report

He, G., Lei, Y., Huang, D.-W., Gao, J., & Yang, R. Z. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04991-w · Cited by 4 · see citing works

Epidemiologie des Bronchialkarzinoms

Becker, N. (2010) · Der Radiologe · doi:10.1007/s00117-009-1956-2 · Cited by 4 · see citing works

Risk-Based and Diagnostics-Linked Personalized Medicine for Cancer

Srivastava, S., & Wagner, P. D. (2007) · Personalized Medicine · doi:10.2217/17410541.4.1.33 · Cited by 4 · see citing works

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer

Osada, H., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205802 · Cited by 220 · see citing works

Retinoblastoma Regulatory Pathway in Lung Cancer

Wikenheiser‐Brokamp, K. A. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070783 · Cited by 42 · see citing works

Genetics of Lung Cancer

Etem, E. Ö. (2013) · DSpace - FIRAT (Fırat University)

New molecular approaches to lung cancer: biological and clinical implications of P53, P16 and K-RAS studies.

Niklinska, W. E., Chyczewski, L., & Nikliński, J. (2001) · PubMed · Cited by 4 · see citing works

Molecular pathology methods and reviews

Driscoll, B. (2003) · Humana Press eBooks · Cited by 2 · see citing works